Profilo
Mei Hui Li currently works at Cinemark Co. Ltd., as Vice Chairman & Chief Executive Officer, CTCI Advanced Systems Inc., as Independent Director from 2014, and Advagene Biopharma Co., Ltd., as Director.
Ms. Li also formerly worked at Taiwan Secom Co., Ltd., as Managing Director and FOCI Fiber Optic Communications, Inc., as Independent Director.
Ms. Li received her graduate degree from National Taiwan University.
Posizioni attive di Mei Hui Li
| Società | Posizione | Inizio |
|---|---|---|
| CTCI ADVANCED SYSTEMS INC. | Direttore/Membro del Consiglio | 26/06/2014 |
| ADVAGENE BIOPHARMA CO., LTD. | Direttore/Membro del Consiglio | - |
Cinemark Co. Ltd. | Amministratore Delegato | - |
Precedenti posizioni note di Mei Hui Li
| Società | Posizione | Fine |
|---|---|---|
| FOCI FIBER OPTIC COMMUNICATIONS, INC. | Direttore/Membro del Consiglio | - |
| TAIWAN SECOM CO., LTD. | Corporate Officer/Principal | - |
Formazione di Mei Hui Li
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Taiwan Secom Co., Ltd.
Taiwan Secom Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Provides system security services | Commercial Services |
CTCI Advanced Systems Inc.
CTCI Advanced Systems Inc. Electrical ProductsProducer Manufacturing Manufactures control system software and hardware | Producer Manufacturing |
National Taiwan University
National Taiwan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
FOCI Fiber Optic Communications, Inc.
FOCI Fiber Optic Communications, Inc. Electrical ProductsProducer Manufacturing Manufactures and sells fiber optic interconnectors | Producer Manufacturing |
Cinemark Co. Ltd. | |
Advagene Biopharma Co., Ltd.
Advagene Biopharma Co., Ltd. BiotechnologyHealth Technology Engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy | Health Technology |
















